LEADER 01542oam  2200481   450 
001 9910716073503321
005 20210817143808.0
035   $a(CKB)5470000002517368
035   $a(OCoLC)1249948942
035   $a(EXLCZ)995470000002517368
100   $a20210506d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 13$aAn Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to the Scope of New Chemical Exclusivity
210  1$a[Washington, D.C.] :$c[U.S. Government Publishing Office],$d[2021]
215   $a1 online resource (4 unnumbered pages)
300   $a"Apr. 23, 2021 (S. 415)."
300   $a"135 Stat. 256."
300   $a"Public Law 117-9."
606   $aDrug approval$zUnited States
606   $aPharmaceutical policy$zUnited States
606   $aDrug approval$2fast
606   $aPharmaceutical policy$2fast
607   $aUnited States$2fast
608   $aStatutes and codes.$2fast
608   $aStatutes and codes.$2lcgft
615  0$aDrug approval
615  0$aPharmaceutical policy
615  7$aDrug approval.
615  7$aPharmaceutical policy.
801  0$bGPO
801  1$bGPO
801  2$bOCLCO
801  2$bOCLCF
801  2$bOCLCQ
801  2$bGPO
906   $aBOOK
912   $a9910716073503321
996   $aAn Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to the Scope of New Chemical Exclusivity$93501891
997   $aUNINA